Correlation Between Alvotech and MEI Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alvotech and MEI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and MEI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and MEI Pharma, you can compare the effects of market volatilities on Alvotech and MEI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of MEI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and MEI Pharma.

Diversification Opportunities for Alvotech and MEI Pharma

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Alvotech and MEI is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and MEI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MEI Pharma and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with MEI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MEI Pharma has no effect on the direction of Alvotech i.e., Alvotech and MEI Pharma go up and down completely randomly.

Pair Corralation between Alvotech and MEI Pharma

Given the investment horizon of 90 days Alvotech is expected to under-perform the MEI Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Alvotech is 1.7 times less risky than MEI Pharma. The stock trades about -0.04 of its potential returns per unit of risk. The MEI Pharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  307.00  in MEI Pharma on August 24, 2024 and sell it today you would lose (26.00) from holding MEI Pharma or give up 8.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Alvotech  vs.  MEI Pharma

 Performance 
       Timeline  
Alvotech 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alvotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Alvotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
MEI Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MEI Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Alvotech and MEI Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alvotech and MEI Pharma

The main advantage of trading using opposite Alvotech and MEI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, MEI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MEI Pharma will offset losses from the drop in MEI Pharma's long position.
The idea behind Alvotech and MEI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Commodity Directory
Find actively traded commodities issued by global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon